{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/2222968/divs/22","sourcedb":"PMC","sourceid":"2222968","divid":22,"text":"Administration of cytokines and antibodies in vivo.\nAge- and gender-matched normal B6 mice received every other day intraperitoneal (ip) injections of PBS, 1.5 \u03bcg rmIL-4, 50 \u03bcg anti-IL-4 mAb (11B11 or MAB404), or a mixture of 1.5 \u03bcg rmIL-4 plus 50 \u03bcg anti-IL-4 mAb (11B11 or MAB404) for 7 d. Thereafter, spleen and lymph node cells were analyzed by flow cytometry for CD3, CD4, and CD25 expression. The anti-mouse IL-4 mAb MAB404 was obtained from R&D Systems, the second anti-mouse IL-4 mAb 11B11 was purchased from eBioscience.","project":"bionlp-st-ge-2016-coref","namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}]}